| Explainability for artificial intelligence in healthcare: a multidisciplinary perspective J Amann, A Blasimme, E Vayena, D Frey, VI Madai, ... BMC medical informatics and decision making 20 (1), 310, 2020 | 2235 | 2020 |
| Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018 | 999 | 2018 |
| Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018 | 267 | 2018 |
| Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018 | 235 | 2018 |
| Operational definition of active and healthy ageing (AHA): a conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19 (9), 955-960, 2015 | 164 | 2015 |
| Health research with big data: time for systemic oversight E Vayena, A Blasimme The journal of law, medicine & ethics 46 (1), 119-129, 2018 | 157 | 2018 |
| Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14 (4), 501-513, 2017 | 155 | 2017 |
| Ethics review of big data research: What should stay and what should be reformed? A Ferretti, M Ienca, M Sheehan, A Blasimme, ES Dove, B Farsides, ... BMC medical ethics 22 (1), 51, 2021 | 120 | 2021 |
| Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018 | 112 | 2018 |
| The ethics of AI in biomedical research, patient care and public health A Blasimme, E Vayena Patient Care and Public Health (April 9, 2019). Oxford Handbook of Ethics of …, 2019 | 103 | 2019 |
| Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2 (1), 14, 2013 | 101 | 2013 |
| Expectations and attitudes towards medical artificial intelligence: a qualitative study in the field of stroke J Amann, E Vayena, KE Ormond, D Frey, VI Madai, A Blasimme PLoS One 18 (1), e0279088, 2023 | 99 | 2023 |
| What's next for COVID-19 apps? Governance and oversight A Blasimme, E Vayena Science 370 (6518), 760-762, 2020 | 95 | 2020 |
| Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017 | 93 | 2017 |
| Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS genetics 9 (2), e1003292, 2013 | 87 | 2013 |
| Democratizing health research through data cooperatives A Blasimme, E Vayena, E Hafen Philosophy & Technology 31 (3), 473-479, 2018 | 77 | 2018 |
| Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016 | 76 | 2016 |
| Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Mañas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015 | 73 | 2015 |
| Digital contact tracing against COVID-19 in Europe: current features and ongoing developments A Blasimme, A Ferretti, E Vayena Frontiers in Digital Health 3, 660823, 2021 | 72 | 2021 |
| Future-proofing biobanks’ governance F Gille, E Vayena, A Blasimme European Journal of Human Genetics 28 (8), 989-996, 2020 | 72 | 2020 |
Effy VayenaETH ZurichVerified email at hest.ethz.ch
